Direct Relief Delivers $1 Billion in Donated Medicine and Medical Supplies ...
Direct Relief Delivers $1 Billion in Donated Medicine and Medical Supplies ...
Source: pr-inside.com
📰 Genentech News
Page 111 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
Gaps in Breast Cancer Receptor Testing for Certain Groups
A review of over 300,000 patients with invasive breast cancer found that breast cancer receptor status testing was less likely to occur in elderly, rural, and Black women.
United States Ohio State University Julie Stephens Electra Paskett Ohio Department Of Health Guardant Health
Source: medscape.com
5 Stocks Wall Street and ARK's Cathie Wood Love Are Trading Under $10 With Huge Upside Potential – 24/7 Wall St.
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with absolutely no track record or liquidity.
Cathie Wood Piper Sandler Adaptive Biotechnologies Corp Wall Street Cogent Biosciences Adaptive Biotechnologies
Source: 247wallst.com
How a visit to a GP 'with a bit of a cough' led to a CANCER diagnosis: 'My lovely elder brother was just 26 when he died of blood cancer, so the mention of it filled me with anxiety,' writes ALEX BRUMMER
ALEX BRUMMER: The word incidental, under most circumstances, does not signify anything of importance. However, I now know differently.
Source: dailymail.co.uk
Analysis of the Global AI in Clinical Trials Industry, 2023 to 2035 - Product/Technology Utilization and Integration Agreements Lead the Way in Partnerships
/PRNewswire/ -- The "Global AI in Clinical Trials Market: Trends and Forecasts 2023-2035" report has been added to ResearchAndMarkets.coms offering. The...
Source: prnewswire.com
Exelixis Announces Appointment of Amy Peterson, M.D., as Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer
23.08.2023 - Exelixis, Inc. (Nasdaq: EXEL) today announced it has appointed Amy Peterson, M.D., its next Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer. Dr. Peterson is a veteran oncology drug development leader whose ... Seite 1
Michaelm Morrissey Vicki Goodman Thomas Jefferson University University Of Chicago Northwestern Memorial Hospital Investigational New Drug
Source: wallstreet-online.de
New kidney tissue model could help assess safety of immunotherapy drugs
A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells.
Source: news-medical.net
Antibody Drug Conjugate (ADC) Markets, 2035
Dublin, Aug. 24, 2023 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market (7th Edition): Distribution by Target Disease Indication, Therapeutic Area,...
United States Roche Kadcyla Immunomedic Trodelvy Daiichi Sankyo Astrazeneca Enhertu Astellas Pharma Astrazeneca Enhertu
Source: globenewswire.com
Atezolizumab Monotherapy Beneficial for NSCLC Ineligible for Platinum-Based Chemo
For patients with non-small cell lung cancer (NSCLC) ineligible for platinum-based chemotherapy, first-line atezolizumab monotherapy is associated with improved overall survival compared to single-agent chemotherapy.
Source: oncologynurseadvisor.com
Genentech Provides Update on Phase III SKYSCRAPER-01 Study in PD-L1-High Metastatic Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group , has been made aware of an inadvertent disclosure of the second interim analysis of the Phase III SKYSCRAPER-01 study, evaluating the investigational...
Source: marketscreener.com